Home › Funds › Erste Asset Management GmbH › AGIO
Erste Asset Management GmbH position in AGIO
AGIOS PHARMACEUTICALS INC · Health Care
Erste Asset Management GmbH reported holding 1,804,900 shares of AGIO (AGIOS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$60.1M, representing 0.45% of its reported portfolio and ranking #44 among its reported holdings. Erste Asset Management GmbH has disclosed AGIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Erste Asset Management GmbH's AGIO position evolved
Erste Asset Management GmbH first disclosed a stake in AGIO in Q3 2023 at 1,694,200 shares (US$41.9M). The position peaked in Q3 2025 at 2,764,900 shares, worth US$108.6M. Across 13 filings, Erste Asset Management GmbH increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,804,900 shares valued at US$60.1M — a reduction of -350,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.69M | $41.93M | New |
| Q4 2023 | 2.11M | $46.98M | Add |
| Q1 2024 | 2.28M | $66.65M | Add |
| Q2 2024 | 2.25M | $97.28M | Reduce |
| Q3 2024 | 2.18M | $97.20M | Reduce |
| Q4 2024 | 2.01M | $66.43M | Reduce |
| Q1 2025 | 2.23M | $65.44M | Add |
| Q2 2025 | 2.33M | $77.40M | Add |
| Q3 2025 | 2.76M | $108.58M | Add |
| Q4 2025 | 2.80M | $76.34M | Add |
| Q1 2026 | 2.70M | $80.09M | Reduce |
| Q2 2026 | 2.15M | $81.97M | Reduce |
| Q3 2026 | 1.80M | $60.10M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AGIO and 13F data
AGIO (AGIOS PHARMACEUTICALS INC) is a Health Care company. 28 other funds we track also report a position in AGIO — the largest reported positions include Farallon Capital Management (US$219.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$219.6M), Lynx1 Capital Management LP (US$126.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AGIO
- Farallon Capital Management 5.92M sh · $219.59M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 5.92M sh · $219.59M · Q2 2026
- Lynx1 Capital Management LP 3.41M sh · $126.51M · Q2 2026
- ARMISTICE CAPITAL, LLC 2.40M sh · $89.06M · Q2 2026
- ADAR1 Capital Management, LLC 1.29M sh · $47.80M · Q2 2026
- Foresite Capital Management VI LLC 785.00K sh · $29.13M · Q2 2026
- Parkman Healthcare Partners LLC 669.05K sh · $24.83M · Q2 2026
More on Erste Asset Management GmbH
FAQ
How long has Erste Asset Management GmbH held AGIO?
Erste Asset Management GmbH has disclosed AGIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Erste Asset Management GmbH's current position in AGIO?
As of Q3 2026, Erste Asset Management GmbH holds 1.80M shares of AGIO (AGIOS PHARMACEUTICALS INC), valued at $60.10M, representing 0.45% of its reported portfolio and ranking #44.
Has Erste Asset Management GmbH been buying or selling AGIO?
In the latest 13F filing (Q3 2026), Erste Asset Management GmbH reduced its position in AGIO. The position peaked in Q3 2025 at 2.76M shares.
Which other funds hold AGIO?
Other major institutional holders of AGIO include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Lynx1 Capital Management LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.